Search results for "MMC"

showing 10 items of 18 documents

The Anti-apoptotic Murine Cytomegalovirus Protein vMIA-m38.5 Induces Mast Cell Degranulation.

2020

Mast cells (MC) represent "inbetweeners" of the immune system in that they are part of innate immunity by acting as first-line sentinels for environmental antigens but also provide a link to adaptive immunity by secretion of chemokines that recruit CD8 T cells to organ sites of infection. An interrelationship between MC and cytomegalovirus (CMV) has been a blank area in science until recently when the murine model revealed a role for MC in the resolution of pulmonary infection by murine CMV (mCMV). As to the mechanism, MC were identified as a target cell type of mCMV. Infected MC degranulate and synthesize the CC-chemokine ligand-5 (CCL-5), which is released to attract protective virus-spec…

0301 basic medicineMicrobiology (medical)Chemokinebone marrow-derived mast cells (BMMC)Muromegalovirusmurine cytomegalovirus030106 microbiologyImmunologygene m38.5lcsh:QR1-502CytomegalovirusApoptosisInhibitor of apoptosisMicrobiologylcsh:MicrobiologyCell Degranulation03 medical and health sciencesMiceImmune systemCellular and Infection MicrobiologyCytotoxic T cellAnimalsperitoneal exudate-derived mast cells (PEMC)Mast CellsdegranulationInnate immune systembiologyDegranulationvirus diseasesTransfectionBrief Research ReportAcquired immune systemCell biologyvMIA030104 developmental biologyInfectious Diseasesbiology.proteinmast cell-specific Cre recombinationApoptosis Regulatory ProteinsFrontiers in cellular and infection microbiology
researchProduct

Estudio clínico y biológico de la leucemia mielomonocítica crónica

2012

La leucemia mielomonocítica crónica (LMMC) es un trastorno hematológico poco frecuente con una expresión clínica y morfológica muy heterogénea, sin embargo, hasta ahora no se ha aceptado ningún sistema pronóstico para los pacientes con LMMC. Los principales objetivos de este estudio fueron evaluar el impacto pronóstico de las alteraciones citogenéticas e identificar los factores pronósticos más relevantes tanto para supervivencia global (SG) como para el riesgo de evolución a leucemia mieloblástica aguda (LMA) en una serie de pacientes con LMMC de novo. Además se desarrolló y validó en una cohorte externa un nuevo sistema de pronóstico específico para la LMMC (CPSS). Para desarrollar el CPS…

:CIENCIAS MÉDICAS::Patología::Hematología [UNESCO]UNESCO::CIENCIAS MÉDICAS::Patología::HematologíacitogenéticaLMMC:CIENCIAS DE LA VIDA::Biología celular::Citogenética [UNESCO]UNESCO::CIENCIAS MÉDICAS::Ciencias clínicas::Genética clínicaLeucemia Mielomonocítica Crónica:CIENCIAS MÉDICAS::Ciencias clínicas::Genética clínica [UNESCO]UNESCO::CIENCIAS DE LA VIDA::Biología celular::Citogenética
researchProduct

A review on basalt fibre and its composites

2015

Abstract In recent years, both industrial and academic world are focussing their attention toward the development of sustainable composites, reinforced with natural fibres. In particular, among the natural fibres (i.e. animal, vegetable or mineral) that can be used as reinforcement, the basalt ones represent the most interesting for their properties. The aim of this review is to illustrate the results of research on this topical subject. In the introduction, mechanical, thermal and chemical properties of basalt fibre have been reviewed. Moreover, its main manufacturing technologies have been described. Then, the effect of using this mineral fibre as reinforcement of different matrices as po…

Basaltchemistry.chemical_classificationA. Metal-matrix composites (MMCs)ThermoplasticMaterials sciencePolymer-matrix compositeA. Ceramic-matrix composites (CMCs)Mechanical EngineeringThermosetting polymerMetal-matrix compositeIndustrial and Manufacturing EngineeringCeramic-matrix compositeA. Polymer-matrix composites (PMCs)Settore ING-IND/22 - Scienza E Tecnologia Dei MaterialichemistryMechanics of MaterialsCeramics and CompositesComposite materialA. Ceramic-matrix composites (CMCs); A. Metal-matrix composites (MMCs); A. Polymer-matrix composites (PMCs); Basalt fibreBasalt fibreComposites Part B: Engineering
researchProduct

Formal and Informal Features in CMMC. Some observation on Dctor-Patient Interaction in Online Communication

2012

CMMC Medical exchange Formal and Informal FeaturesSettore L-LIN/12 - Lingua E Traduzione - Lingua Inglese
researchProduct

Sicurezza ed Efficacia dell’ Inserto Ologen™ Nella Chirurgia Del Glaucoma: Risultati Di Uno Studio Prospettico Di Fase II.

2009

Glaucoma surgery Ologen MMC
researchProduct

"Table 5" of "Test of CP invariance in vector-boson fusion production of the Higgs boson in the H → ττ channel in proton–proton collisions at s=13TeV…

2020

Post-fit $m_{\tau\tau}^{\mathrm{MMC}}$ distributions in the low BDT score CR for the $\tau_{\mathrm{lep}}\tau_{\mathrm{lep}}$ SF analysis channel. ''Other bkg'' denotes all background contributions not listed explicitly in the legend. The size of the combined statistical, experimental, and theoretical uncertainties is given. The exact value of the $p_{\mathrm{T}}$ cut on the leptons depends on the trigger.

Higgs Production13000.0Proton-Proton ScatteringHigh Energy Physics::PhenomenologyTau-Tau DecayHigh Energy Physics::ExperimentP P -> H + XMMC
researchProduct

"Table 8" of "Test of CP invariance in vector-boson fusion production of the Higgs boson in the H → ττ channel in proton–proton collisions at s=13TeV…

2020

Post-fit $m_{\tau\tau}^{\mathrm{MMC}}$ distributions in the low BDT score CR for the $\tau_{\mathrm{had}}\tau_{\mathrm{had}}$ analysis channel. ''Other bkg'' denotes all background contributions not listed explicitly in the legend. The size of the combined statistical, experimental, and theoretical uncertainties is given.

Higgs Production13000.0Proton-Proton ScatteringTau-Tau DecayP P -> H + XMMC
researchProduct

"Table 6" of "Test of CP invariance in vector-boson fusion production of the Higgs boson in the H → ττ channel in proton–proton collisions at s=13TeV…

2020

Post-fit $m_{\tau\tau}^{\mathrm{MMC}}$ distributions in the low BDT score CR for the $\tau_{\mathrm{lep}}\tau_{\mathrm{lep}}$ DF analysis channel. ''Other bkg'' denotes all background contributions not listed explicitly in the legend. The size of the combined statistical, experimental, and theoretical uncertainties is given.

Higgs Production13000.0Proton-Proton ScatteringTau-Tau DecayP P -> H + XMMC
researchProduct

"Table 7" of "Test of CP invariance in vector-boson fusion production of the Higgs boson in the H → ττ channel in proton–proton collisions at s=13TeV…

2020

Post-fit $m_{\tau\tau}^{\mathrm{MMC}}$ distributions in the low BDT score CR for the $\tau_{\mathrm{lep}}\tau_{\mathrm{had}}$ analysis channel. ''Other bkg'' denotes all background contributions not listed explicitly in the legend. The size of the combined statistical, experimental, and theoretical uncertainties is given. The exact value of the $p_{\mathrm{T}}$ cut on the leading lepton depends on the trigger.

Higgs Production13000.0Proton-Proton ScatteringTau-Tau DecayP P -> H + XMMC
researchProduct

Biodegradable collagen matrix implant vs mitomycin-C as an adjuvant in trabeculectomy: a 24-month, randomized clinical trial

2011

AIM: To verify the safety and efficacy of Ologen (OLO) implant as adjuvant compared with low-dosage mitomycin-C (MMC) in trabeculectomy. METHODS: This was a prospective randomized clinical trial with a 24-month follow-up. Forty glaucoma patients (40 eyes) were assigned to trabeculectomy with MMC or OLO. Primary outcome includes target IOP at ≤21, ≤17, and ≤15 mm Hg; complete (target IOP without medications), and qualified success (target IOP regardless of medications). Secondary outcomes include bleb evaluation, according to Moorfields Bleb Grading System (MBGS); spectral domain optical coherence tomography (SD-OCT) examination; number of glaucoma medications; and frequency of postoperative…

MaleIntraocular pressuremedicine.medical_specialtymedicine.medical_treatmentMitomycinGlaucomaTrabeculectomyMatrix (biology)law.inventionRandomized controlled triallawAbsorbable ImplantsmedicineTrabeculectomyHumansProspective StudiesIntraocular PressureAgedGlycosaminoglycansIntraoperative CareSettore MED/30 - Malattie Apparato Visivobusiness.industryMitomycin CGlaucomaProstheses and ImplantsMiddle AgedOlogen MMC trabeculectomymedicine.diseaseSurgeryOphthalmologyCross-Linking ReagentsClinical StudyFemaleImplantCollagenbusinessAdjuvantTomography Optical Coherence
researchProduct